Advertisement

Plant Metabolites as New Leads to Anticancer Drug Discovery: Approaches and Challenges

  • Sagar Satish Datir
Chapter

Abstract

Cancer is one of the most life-threatening diseases widely affecting the mortality of the world’s population. Anticancer therapies such as radiation treatment, chemotherapy, and surgery have gained limited success in cancer treatment, and therefore, there is a need to develop an alternative method to treat chronic diseases like cancer. Medicinal plants and plant foods such as vegetables and fruits are in use to treat human diseases since prehistoric times because of their health-promoting effects. Certainly, there is an increased public awareness regarding the use of medicinal plants in treating human diseases as they are promising source of drugs with minimal or no side effects. Plant metabolites from various parts of medicinal plants have attracted attention of researchers and pharmaceutical industries in treating cancer due to their indispensable use with reduced side effects. With the advent of techniques such as transgenics, bioinformatics, metabolomics, and nanotechnology, plant metabolites offer opportunities to anticancer drug discovery. The use of phytochemicals, computational approaches in drug design, the efficacy and efficiency, the mode of action, and further clinical studies might provide new avenues in cancer research. Plant-derived anticancer compounds are currently being used in clinical studies and are currently being investigated phytochemically to understand their antitumor actions against various cancers. The present chapter summarizes the information on anticancer medicinal plants and their derived phytochemicals or metabolites and also on the development of plant-derived substances to treat cancer.

Keywords

Alkaloids Anticancer Drug Medicinal plants Metabolites 

References

  1. Agarwal S, Amin KS, Jagadeesh S, Baishay G, Rao PG, Barua NC, Bhattacharya S, Banerjee PP (2013) Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells. Mol Cancer 3:12–99Google Scholar
  2. Ahmad A, Sakr WA, Rahman KM (2012) Novel targets for detection of cancer and their modulation by chemopreventive natural compounds. Front Biosci 4:410–425CrossRefGoogle Scholar
  3. Ali I, Rahis U, Salim K, Rather MA, Wani WA, Haque A (2011) Advances in nano drugs for cancer chemotherapy. Curr Cancer Drug Targets 11:135–146PubMedCrossRefGoogle Scholar
  4. Almagro L, Fernández-Pérez F, Angeles Pedreño M (2015) Indole alkaloids from Catharanthus roseus: bioproduction and their effect on human health. Molecules 20:2973–3000PubMedCrossRefGoogle Scholar
  5. Alonso-Castro AJ, Villarreal ML, Salazar-Olivo LA, Gomez-Sanchez M, Dominguez F, Garcia-Carranca A (2011) Mexican medicinal plants used for cancer treatment: pharmacological, phytochemical and ethnobotanical studies. J Ethnopharmacol 133:945–972PubMedCrossRefGoogle Scholar
  6. Anand C, Neetu S (2011) Contribution of world health organization in the global acceptance of Ayurveda. J Ayurv Integr Med 2:179–186CrossRefGoogle Scholar
  7. Andreoli F, Barbosa AJM, Parenti MD, Rio AD (2013) Modulation of epigenetic targets for anticancer therapy: Clinicopathological relevance, structural data and drug discovery perspectives. Curr Pharm Des 19:578–613PubMedCrossRefGoogle Scholar
  8. Atanasov AG, Waltenberger B, Pferschy-Wenzig EM, Linderd T, Wawroscha C, Uhrine P, Temmlf V, Wanga L, Schwaigerb S, Heissa EH, Rollingera JM, Schusterf D, Breusse JM, Bochkovg V, Mihovilovicd MD, Koppa B, Bauerc R, Dirscha VM, Stuppner H (2015) Discovery and resupply of pharmacologically active plant-derived natural products: a review. Biotechnol Adv 33:1582–1614PubMedPubMedCentralCrossRefGoogle Scholar
  9. Berger A, Venturelli S, Kallnischkies M, Bocker A, Busch C, Weiland T, Noor S, Leischner C, Weiss TS, Lauer UM, Bischoff SC, Bitzer M (2013) Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases. J Nutr Biochem 24:977–985PubMedCrossRefGoogle Scholar
  10. Bernhoft A (2010) Bioactive compounds in plants benefits and risks for man and animals. Proceedings from a symposium held at The Norwegian Academy of Science and Letters, Oslo, 13–14 November 2008. National Veterinary Institute, Oslo, Norway, and Committee for Information and Research in Geomedicine, The Norwegian Academy of Science and Letters, OsloGoogle Scholar
  11. Bhandari M, Bhandari A, Prakash R, Bhandari A (2010) Scutellaria baicalensis Georgi: a rising paradigm of herbal remedies. Pharm Sci 1:1–8Google Scholar
  12. Blekherman G, Laubenbacher R, Cortes DF, Mendes P, Torti FM, Akman S, Torti SV, Shulaev V (2011) Bioinformatics tools for cancer development. Metabolomics 3:329–343CrossRefGoogle Scholar
  13. Bombonati A, Sgroi DC (2011) The molecular pathology of breast cancer progression. J pathology 223:307–317CrossRefGoogle Scholar
  14. Busch C, Burkard M, Leischner C, Lauer UM, Frank J, Venturelli S (2015) Epigenetic activities of flavonoids in the prevention and treatment of cancer. Clin Epigene 7:1–18CrossRefGoogle Scholar
  15. Campbell R, Freitag S, Bryan GJ, Stewart D, Taylor MA (2016) Environmental and genetic factors associated with solanesol accumulation in potato leaves. Front Plant Sci 7:1263PubMedPubMedCentralCrossRefGoogle Scholar
  16. Cha TL, Chuang MJ, Tang SH, Wu ST, Sun KH, Chen TT, Sun GH, Chang SY, Yu CP, Ho JY, Liu SY, Huang SM, Yu DS (2013) Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growth. Mol Carcinog 54:167–177PubMedCrossRefGoogle Scholar
  17. Chang CH, Huang WY, Lai CH, Hsu YM, Yao YH, Chen TY (2011) Development of novel nanoparticles shelled with heparin for Berberine delivery to treat Helicobacter pylori. Acta Biomater 7:593–603PubMedCrossRefGoogle Scholar
  18. Chen Y, Lin X, Park H, Greever R (2009) Study of artemisinin nanocapsules as anticancer drug delivery systems. Nanomedicine 5:316–322PubMedCrossRefGoogle Scholar
  19. Chung IM, Thiruvengadam M, Rekha K, Rajakumar G (2016) Elicitation enhanced the production of phenolic compounds and biological activities in hairy root cultures of bitter melon (Momordica charantia L.) Braz Arch Biol Technol 59:1–10CrossRefGoogle Scholar
  20. Cui L, Ni X, Ji Q, Teng X, Yang Y, Wu C, Zekria D, Zhang D, Kail G (2015) Co-overexpression of geraniol-10-hydroxylase and strictosidine synthase improves anti-cancer drug camptothecin accumulation in Ophiorrhiza pumila. Sci Rep 5:8227PubMedPubMedCentralCrossRefGoogle Scholar
  21. Dai J, Mumper RJ (2010) Plant phenolics: extraction, analysis and their antioxidant and anticancer properties. Molecules 15:7313–7352PubMedCrossRefGoogle Scholar
  22. Das S, Das J, Samadder A, Bhattacharyya SS, Das D, Khuda-Bukhsh AR (2013) Biosynthesized silver nanoparticles by ethanolic extracts of Phytolacca decandra, Gelsemium sempervirens, Hydrastis canadensis and Thuja occidentalis induce differential cytotoxicity through G2/M arrest in A375 cells. Colloid Surf B 101:325–336CrossRefGoogle Scholar
  23. Dawood M, Efferth T (2015) Medicinal plants and DNA methylation of cancer. Med Aromat Plants 4:1–4CrossRefGoogle Scholar
  24. Diaconeasa Z, Leopold L, Rugină D, Ayvaz H, Socaciu C (2015) Antiproliferative and antioxidant properties of anthocyanin rich extracts from blueberry and blackcurrant juice. Int J Mol Sci 16:2352–2365PubMedPubMedCentralCrossRefGoogle Scholar
  25. Dipankar C, Murugan S (2012) The green synthesis, characterization and evaluation of the biological activities of silver nanoparticles synthesized from Iresine herbstii leaf aqueous extracts. Colloid Surf B 98:112–119CrossRefGoogle Scholar
  26. Duwensee K, Schwaiger S, Tancevski I, Eller K, van Eck M, Markt P et al (2011) Leoligin, the major lignan from Edelweiss, activates cholesteryl ester transfer protein. Atherosclerosis 219:109–115PubMedPubMedCentralCrossRefGoogle Scholar
  27. Filová A, Rovna K (2011) Explantate culture of yew (Taxus sp.) as alternative production systems for taxane metabolites. Acta Hortic Regiotect 14:19–23Google Scholar
  28. Folashade KO, Omoregie EH, Ochogu AP (2012) Standardization of herbal medicines-a review. Int J Biodivers Conserv 4:101–112Google Scholar
  29. Gajalakshmi S, Vijayalakshmi S, Devi Rajeswari V (2013) Pharmacological activities of Catharanthus Roseus: a perspective review. Int J Pharm Chem Biol Sci 4:431–439Google Scholar
  30. Gaviraj EN, Veeresham C (2011) Enhanced alkaloid production by elicitation in hairy root cultures of Catharanthus roseus var Nimal. Indian Drugs 48:20–25Google Scholar
  31. Gomez-Casati DF, Zanor MI, Busi MV (2013) Metabolomics in plants and humans: applications in the prevention and diagnosis of diseases. Biomed Res Int 2013:1–13CrossRefGoogle Scholar
  32. Greenwell M, Rahman PKSM (2015) Medicinal plants: their use in anticancer treatment. Int J Pharm Sci Res 1:4103–4112Google Scholar
  33. Gupta S, Liu RB, Liaw SY, Chan HS, Tsay HS (2011) Enhanced tanshinone production in hairy roots of ‘Salvia miltiorrhiza Bunge’ under the influence of plant growth regulators in liquid culture. Bot Stud 52:435–443Google Scholar
  34. Hashemi M, Behrangi N, Farahani E (2014) Bioinformatic analysis for anticancer effects of flavonoids in vegetables and fruits. International conference on Biological, Civil and Environmental Engineering (BCEE-2014) 17–18th March, DubaiGoogle Scholar
  35. Heidel JD, Davis ME (2011) Clinical developments in nanotechnology for cancer therapy. Pharm Res 28:187–199PubMedCrossRefGoogle Scholar
  36. Hein M, Zilian D, Sotriffer CA (2010) Docking compared to 3D-pharmacophores: the scoring function challenge. Drug Discov Today Technol 7:229–236CrossRefGoogle Scholar
  37. Hu CMJ, Aryal S, Zhang L (2010) Nanoparticle-assisted combination therapies for effective cancer treatment. Ther Deliv 1:323–334PubMedCrossRefGoogle Scholar
  38. Huang J, Plass C, Gerhauser C (2011) Cancer chemoprevention by targeting the epigenome. Curr Drug Targets 12:1925–1956PubMedCrossRefGoogle Scholar
  39. Huang T, Lin C, Linda LD, Zhong ZL, Zhang GA, Wu J, Bian Z (2017) Targeting histone methylation for colorectal cancer. Ther Adv Gastroenterol 10:114–131CrossRefGoogle Scholar
  40. Jain AK, Das M, Swarnakar NK, Jain S (2011) Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics. Crit Rev Ther Drug Carrier Syst 28:1–45PubMedCrossRefGoogle Scholar
  41. Jena J, Gupta AK (2012) Ricinus communis Linn: a Phytopharmacological review. Int J Pharm Pharm Sci 4:25–29Google Scholar
  42. Kainsa S, Kumar P, Rani P (2012) Medicinal plants of Asian origin having anticancer potential: short review. Asian J Biomed Pharma Sci 2:1–7Google Scholar
  43. Karius T, Schnekenburger M, Dicato M, Diederich M (2012) MicroRNAs in cancer management and their modulation by dietary agents. Biochem Pharmacol 83:1591–1601PubMedCrossRefGoogle Scholar
  44. Kasliwal RR, Madhu DM, Mary Minz MD (2017) Managing cancer patients: the heart really matters. J Clinic Prev Card 6:60–67Google Scholar
  45. Kaur R, Kapoor K, Kaur H (2011) Plants as a source of anticancer agents. J Nat Prod Plant Resour 1:119–124Google Scholar
  46. Kaushal S, Arush S, Dev K (2014) In vitro plant production through apical meristem culture of Gentiana kurroo Royl. J Med Plant Stud 3:4–9Google Scholar
  47. Khani S, Barar J, Movafeghi A, Omdi Y (2012) Production of anticancer medicinal metabolites: impacts of bioprocess engineering. In: Orhan I (ed) Biotechnological production of plant secondary metabolites. Bentham Science Publishers, Dubai, pp 215–240CrossRefGoogle Scholar
  48. Khazir J, Mir BA, Pilcher L, Riley DL (2014) Role of plants in anticancer drug discovery. Phytochem Lett 7:173–181CrossRefGoogle Scholar
  49. Kim HK, Wilson EG, Choi YH, Verpoorte R (2010) Metabolomics: a tool for anticancer lead-finding from natural products. Planta Med 76:1094–1102PubMedCrossRefGoogle Scholar
  50. Kim B, Kim SH, Jeong SJ, Sohn EJ, Jung JH, Lee MH et al (2012) Brazilin induces apoptosis and G2/M arrest via inactivation of histone deacetylase in multiple myeloma U266 cells. J Agric Food Chem 60:9882–9889PubMedCrossRefGoogle Scholar
  51. Kumar S, Mishra A, Pandey AK (2013) Antioxidant mediated protective effect of Parthenium hysterophorus against oxidative damage using in vitro models. BMC Compl Altern Med 13:120CrossRefGoogle Scholar
  52. Kumari A, Kumar V, Yadav SK (2012) Nanotechnology: a tool to enhance therapeutic values of natural plant products. Trends Med Res 7:34–42CrossRefGoogle Scholar
  53. Kuppusamy P, Mafhitah MY, Gaanty PM, Goviandan N (2016) Biosynthesis of metallic nanoparticles using plant derivatives and their new avenues in pharmacological applications: an update report. Saudi Pharm J 24:473–484PubMedCrossRefGoogle Scholar
  54. Lahlou M (2013) The success of natural products in drug discovery. Pharmacol Pharm 4:17–31CrossRefGoogle Scholar
  55. Link A, Balaguer F, Goel A (2010) Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmacol 80:1771–1792PubMedPubMedCentralCrossRefGoogle Scholar
  56. Lu X, Tang K, Li P (2016) Plant metabolic engineering strategies for the production of pharmaceutical Terpenoids. Front Plant Sci 7:1647Google Scholar
  57. Lustberg MB, Ramaswamy B (2010) Epigenetic therapy in breast cancer. Curr Breast Cancer Rep 3:34–43CrossRefGoogle Scholar
  58. Mehta J, Upadhyay D, Paras P, Ansari R, Rathore S, Tiwari S (2013) Multiple shoots regeneration of (anti-cancer plant) Catharanthus roseus-an important medicinal plant. Am J PharmTech Res 30:785–793Google Scholar
  59. Mendoza-Poudereux I, Muñoz-Bertomeu J, Navarro A, Arrillaga I, Segura J (2014) Enhanced levels of S-linalool by metabolic engineering of the terpenoid pathway in spike lavender leaves. Metab Eng 23:136–144PubMedCrossRefGoogle Scholar
  60. Misawa N (2011) Pathway engineering for functional isoprenoids. Curr Opin Biotechnol 22:627–633PubMedCrossRefGoogle Scholar
  61. Mohammed A, Chiruvella KK, Rao YK, Geethangili M, Raghavan SC, Ghanta RG (2015) In vitro production of echioidinin, 7-OMethywogonin from callus cultures of Andrographis lineata and their cytotoxicity on cancer cells. PLoS One 10:1–14PubMedPubMedCentralCrossRefGoogle Scholar
  62. Mukherjee PK, Harwansh RK, Bahadur S, Biswas S, Kuchibhatla LN, Tetali SD, Raghavendra AS (2016) Metabolomics of medicinal plants–a versatile tool for standardization of herbal products and quality evaluation of Ayurvedic formulations. Curr Sci 111:1624–1630CrossRefGoogle Scholar
  63. Nayak AP, Waree T, Swati P, Basavaraj M, Eliana BS (2010) Curcuminoids-loaded lipid nanoparticles: novel approach towards malaria treatment. Colloids and Surfaces B 81:263–273CrossRefGoogle Scholar
  64. Nema R, Khare S, Jain P, Pradhan A, Gupta A, Singh D (2013) Natural products potential and scope for modern cancer research. Am J Plant Sci 4:1270–1277CrossRefGoogle Scholar
  65. Nguyen KT (2011) Targeted nanoparticles for cancer therapy: promises and challenges. J Nanomed Nanotechnol 2:1–2CrossRefGoogle Scholar
  66. Paluszczak J, Krajka-Kuzniak V, Baer-Dubowska W (2010) The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. Toxicol Lett 192:119–125PubMedCrossRefGoogle Scholar
  67. Pan Q, Wang Q, Yuan F, Xing S, Zhao J, Choi YH, Verpoorte R, Tian Y, Wang G, Tang K (2012) Overexpression of ORCA3 and G10H in Catharanthus roseus plants regulated alkaloid biosynthesis and metabolism revealed by NMR-metabolomics. PLoS One 7:e43038.  https://doi.org/10.1371/journal.pone.0043038 CrossRefPubMedPubMedCentralGoogle Scholar
  68. Pandey A, Pandey G (2013) Usefulness of nanotechnology for herbal medicines. Plant Arch 13:617–621Google Scholar
  69. Pandey S, Bahadur AN, Kanungo K, Tiwari U (2014) In vitro propagation of a medicinal plant Catharanthus roseus L. (G.) Don. Indian. J Life Sci 4:125–128Google Scholar
  70. Prakash O, Kumar A, Kumar P, Ajeet (2013) Anticancer potential of plants and natural products: a review. Am J Pharmacol Sci 1:104–115Google Scholar
  71. Priyadarshini K, Keerthi Aparajitha U (2012) Paclitaxel against cancer: a short review. Med Chem 2:139–141Google Scholar
  72. Raghunandan D, Ravishankar B, Sharanbasava G, Mahesh DB, Harsoor V, Yalagatti MS, Bhagawanraju M, Venkataraman A (2011) Anti-cancer studies of noble metal nanoparticles synthesized using different plant extracts. Cancer Nanotechnol 2:57–65PubMedPubMedCentralCrossRefGoogle Scholar
  73. Raghvendra SV, Shakya A, Hedaytullah MD, Arya GS, Mishra A, Deo Gupta A, Pachpute AP, Patel D (2011) Chemical and potential aspects of anthocyanins-a water soluble vacuolar flavonoid pigments: A review. Int J Pharma Sci Rev Res 6:28–33Google Scholar
  74. Rahman MA, Harwansh R, Mirza MA, Hussain S, Hussain A (2011) Oral Lipid Based Drug Delivery System (LBDDS): formulation, characterization and application: a review. Curr Drug Deliv 8:1–16CrossRefGoogle Scholar
  75. Raina H, Soni G, Jauhari N, Sharma N, Bharadvaja N (2014) Phytochemical importance of medicinal plants as potential sources of anticancer agents. Turk J Bot 38:1027–1035CrossRefGoogle Scholar
  76. Rajeshkumar S (2016) Anticancer activity of eco-friendly gold nanoparticles against lung and liver cancer cells. J Genet Eng Biotechnol 14:195–202CrossRefGoogle Scholar
  77. Rajkumar M, Harish Chandra R, Veeresham C (2010) Production of Nitidine from callus cultures of Toddalia asiatica. Int J of Pharm Sci Nanotech 2:1028–1033Google Scholar
  78. Rao PV, Nallappan D, Madhavi K, Rahman S, Wei LJ, Gan SH (2016) Phytochemicals and biogenic metallic nanoparticles as anticancer agents. Oxidat Med Cell Longe 2016:3685671.  https://doi.org/10.1155/2016/3685671 CrossRefGoogle Scholar
  79. Rathinamoorthy R, Thilagavathi G (2014) Terminalia Chebula review on pharmacological and biochemical studies. Int J PharmTech Res 6:97–116Google Scholar
  80. Rietjens IM, Sotoca AM, Vervoort J, Louisse J (2013) Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks. Mol Nutr Food Res 57:100–113PubMedCrossRefGoogle Scholar
  81. Ritala A, Dong L, Imseng N, Seppänen-Laakso T, Vasilev N, van der Krol S, Maaheimo H, Virkki A, Brändli J, Schillberg S, Eibl R, Bouwmeester H, Oksman-Caldentey KM (2014) Evaluation of tobacco (Nicotiana tabacum L. cv Petit Havana SR1) hairy roots for the production of geraniol, the first committed step in terpenoid indole alkaloid pathway. J Biotechnol 176:20–28PubMedCrossRefGoogle Scholar
  82. Robinson MM, Zhang X (2011) The world medicines situation 2011 traditional medicines: global situation, issues and challenges. World Health Organization, Geneva, pp 1–12Google Scholar
  83. Rollinger JM, Stuppner H, Langer T (2008) Virtual screening for the discovery of bioactive natural products. Prog Drug Res 65:213–249Google Scholar
  84. Romagnolo DF, Selmin OI (2012) Flavonoids and cancer prevention: a review of the evidence. J Nutr Gerontol Geriatr 31:206–238PubMedCrossRefGoogle Scholar
  85. Saikia M, Handique PJ (2014) In vitro propagation of Acalypha indica Linn: a medicinally important plant. Int J Life Sci Biotechnol Pharm Res 3:85–93Google Scholar
  86. Saito K, Matsuda F (2010) Metabolomics for functional genomics, systems biology, and biotechnology. Annu Rev Plant Biol 61:463–489PubMedCrossRefGoogle Scholar
  87. Schneider-Stock R, Ghantous A, Bajbouj K, Saikali M, Darwiche N (2012) Epigenetic mechanisms of plant-derived anticancer drugs. Front Biosci 17:129–173CrossRefGoogle Scholar
  88. Schnekenburger M, Dicato M, Diederich M (2014) Plant-derived epigenetic modulators for cancer treatment and prevention. Biotechnol Adv 32:1123–1132PubMedCrossRefGoogle Scholar
  89. Serkova NJ, Glunde K (2009) Metabolomics of cancer. Methods Mol Biol 520:273–295PubMedCrossRefGoogle Scholar
  90. Shabani A (2015) A review of anticancer properties of herbal medicines. J Pharma Care Health Sys 3:1–4Google Scholar
  91. Shakya AK (2016) Medicinal plants: future source of new drugs. Int J Herb Med 4:59–64Google Scholar
  92. Sharma V (2013) Part based HPLC-PDA quantification of Podophyllotoxin in populations of Podophyllum hexandrum Royle indian Mayapple from higher altitude himalayas. J Med Plants Studies 1:176–183Google Scholar
  93. Sharma V, Sarkar IN (2012) Bioinformatics opportunities for identification and study of medicinal plants. Brief Bioinform 14:238–250PubMedPubMedCentralCrossRefGoogle Scholar
  94. Sheikhpour S, Yadollahi P, Fakheri BA, Amiri A (2014) Biotechnological strategies for conservation of rare medicinal plants. I Intl J Agri Crop Sci 7:79–82Google Scholar
  95. Shen B (2015) A new golden age of natural products drug discovery. Cell 163:1297–1300PubMedPubMedCentralCrossRefGoogle Scholar
  96. Shiyou L, Wanli Z (2014) Ethnobotany of Camptotheca decaisne: new discoveries of old medicinal uses. Pharmaceutical Crops 5:140–145CrossRefGoogle Scholar
  97. Shoeb M, Celik S, Jaspars M, Kumarasamy Y, MacManus S, Nahar L, Kong TLP, Sarker SD (2006) Isolation, structure elucidation and bioactivity of schischkiniin, a unique indole alkaloid from the seeds of Centaurea schischkinii. Tetrahedron 61:9001–9006CrossRefGoogle Scholar
  98. Siahsar B, Rahimi M, Tavassoli A, Raissi AS (2011) Application of biotechnology in production of medicinal plants. American-Eurasian J Agric Environ Sci 11:439–444Google Scholar
  99. Singh R, Tiwari S, Tawaniya J (2013) Review on nanotechnology with several aspects. Int J Res Comput Eng Electron 2:1–8Google Scholar
  100. Song YH, Sun H, Zhang A-H, Yan G, Han Y, Wang X (2014) Plant-derived natural products as leads to anti-cancer drugs. J Med Plants Herbal Ther Res 2:6–15Google Scholar
  101. Steindl TM, Schuster D, Laggner C, Chuang K, Hoffmann RD, Langer T (2007) Parallel screening and activity profiling with HIV protease inhibitor pharmacophore models. J Chem Inf Model 47:563–571PubMedCrossRefGoogle Scholar
  102. Suman TY, Rajasree SR, Kanchana A, Elizabeth SB (2013) Biosynthesis, characterization and cytotoxic effect of plant mediated silver nanoparticles using Morinda citrifolia root extract. Colloids Surf B Biointerfaces 106:74–78PubMedCrossRefGoogle Scholar
  103. Sun J, Manmathan H, Sun C, Peebles CAM (2016) Examining the transcriptional response of overexpressing anthranilate synthase in the hairy roots of an important medicinal plant Catharanthus roseus by RNA-seq. BMC Plant Biol 16:108.  https://doi.org/10.1186/s12870-016-0794-4 CrossRefPubMedPubMedCentralGoogle Scholar
  104. Teiten MH, Dicato M, Diederich M (2013) Curcumin as a regulator of epigenetic events. Mol Nutr Food Res 57:1619–1629PubMedCrossRefGoogle Scholar
  105. Thakur VS, Deb G, Babcook MA, Gupta S (2014) Plant phytochemicals as epigenetic modulators: role in cancer chemoprevention. AAPS J 16:151–163PubMedCrossRefGoogle Scholar
  106. Thingujam D, Rekha K, Megala J, Usha B (2015) Antioxidant and anticancer properties of Catharanthus pusillus. Int J Adv Che Sci App 3:48–51Google Scholar
  107. Tomassini A, Sciubba F, Di Cocco ME, Capuani G, Delfini M, Aureli W, Miccheli A (2016) One H NMR based metabolomics reveal pedoclimatic metabolic imprinting in ready to drink Carrot juices. J Agric Food Chem 64:5284–5291PubMedCrossRefGoogle Scholar
  108. Umadevi M, Rajeswari R, Sharmila Rahale C, Selvavenkadesh S, Pushpa R, Sampath KP, Bhowmik D (2012) Traditional and medicinal uses of Withania somnifera. Pharma Innov 1:102–110Google Scholar
  109. Veeck J, Esteller M (2010) Breast cancer epigenetics: from DNA methylation to microRNAs. J Mammary Gland Biol Neoplasia 15:5–17PubMedPubMedCentralCrossRefGoogle Scholar
  110. Veeresham C, Chitti P (2013) Therapeutic agents from tissue cultures of medicinal plants. Nat Prod Chem Res 1:1–5CrossRefGoogle Scholar
  111. Verma M, Banerjee HN (2015) Metabolomic approaches in cancer epidemiology. Diseases 3:167–175PubMedPubMedCentralCrossRefGoogle Scholar
  112. Wassim NS, El-Sibai M, Kikki B-S, Marc CK, Mohamad M, Costantine FD (2013) The antioxidant and anticancer effects of wild carrot oil extract. Phytother Res 27:737–744CrossRefGoogle Scholar
  113. Waszkowycz B, Clark DE, Gancia E (2011) Outstanding challenges in protein-ligand docking and structure-based virtual screening. Wiley Interdiscip Rev Comput Mol Sci 1:229–259CrossRefGoogle Scholar
  114. Wink M (2010) Annual plant reviews. In: Wink M (ed) Introduction: Biochemistry, physiology and ecological functions of secondary metabolites. Wiley, Chichester, pp 1–19Google Scholar
  115. Wojakowska A, Chekan M, Widlak P, Pietrowska M (2015) Application of metabolomics in thyroid cancer research. Int J Endocrinol 2015:258763.  https://doi.org/10.1155/2015/258763 CrossRefPubMedPubMedCentralGoogle Scholar
  116. Wolber G, Rollinger JM (2013) Virtual screening and target fishing for natural products using 3D pharmacophores. In: Edgar J (ed) Computational Chemogenomics. Pan Stanford Publishing Pvt Ltd, Singapore, pp 117–139CrossRefGoogle Scholar
  117. Wurtele EV, Chappell J, Jones AD, Celiz MD, Ransom N, Hur M, Rizschsky L, Crispin M, Dixon P, Liu J, Widrlechher MP, Nikolau BJ (2012) Medicinal plants: a public resource for metabolomics and hypothesis development. Metabolites 2:1031–1059PubMedPubMedCentralCrossRefGoogle Scholar
  118. Yadav A, Ghune M, Jain DK (2011) Nano-medicine based drug delivery system. J Adv Pharm Educ Res 1:201–213Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  1. 1.Department of BiotechnologySavitribai Phule Pune UniversityPuneIndia

Personalised recommendations